MannKind prices USD 50 million private placement at USD 3.89 per share
MNKD•Private placement terms and use of proceeds
MannKind set a private placement expected to raise about USD 50 million in gross proceeds, with closing expected on or about July 24, 2026.
- Sale includes 10,440,838 common shares, with pre-funded warrants for up to 2,412,632 shares in lieu of stock for some investors.
- Pricing set at USD 3.89 per share, USD 3.88 per pre-funded warrant; warrants carry a USD 0.01 exercise price.
- Proceeds earmarked for general corporate purposes, including funding a USD 45 million CVR payment tied to Furoscix ReadyFlow FDA approval.
- Securities sold in an unregistered offering under Section 4(a)(2); resale registration statement to be filed with the SEC.
